Biotechnology News

July 23, 2014

BURLINGTON, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ: DYAX) today announced the online publication of scientific data for DX-2930, an investigational fully human monoclonal antibody inhibitor of plasma kallikrein (pKal), in two peer-reviewed...

July 23, 2014

SAN DIEGO--(BUSINESS WIRE)--bioTheranostics, Inc., the leading genomic solutions provider for cancer diagnosis, announced the addition of Ramesh Hariharan, Ph.D., to senior management as vice president of marketing.

July 23, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Gen9, Inc., the pioneer in the development of scalable technologies for synthesizing and assembling DNA, today announced the commercial launch of GeneByte Plus™ DNA constructs, synthesized at lengths ranging...

July 23, 2014

BEDMINSTER, N.J. & RESEARCH TRIANGLE PARK, N.C. & NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) announced today that its second quarter 2014 financial results will be released after the market closes on...

July 23, 2014

WEST HAVEN, Conn.--(BUSINESS WIRE)--President, Dr. Anil Diwan, was invited to participate in the CEO Roundtable on the Expanded Role of CFO, and CEO of the Year Felicitation Event held at the New York Stock Exchange on July 17, 2014.

July 23, 2014

PARSIPPANY, N.J.--(BUSINESS WIRE)--The Medicines Company (NASDAQ:MDCO), a global company focused on saving lives, alleviating suffering, and contributing to the economics of healthcare by focusing on the world's leading acute/intensive care...

July 23, 2014

WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (“Eagle” or “the Company”) (Nasdaq:EGRX) today announced that the U. S. Food and Drug Administration (FDA) has approved Ryanodex® (dantrolene sodium) for injectable suspension...

July 23, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--BIOGEN IDEC SECOND QUARTER 2014 REVENUES INCREASE 40% TO $2.4 BILLION; COMPANY RAISES FINANCIAL GUIDANCE FOR THE YEAR

July 23, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--SAGE Therapeutics Announces Closing of Initial Public Offering

July 23, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the second quarter ended June 28, 2014, the first full quarter including the Life...

July 23, 2014

HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy's Laboratories (NYSE: RDY) will announce results for the First Quarter ended June 30, 2014 on Wednesday, July 30, 2014 after the Board Meeting. The results will be available on the Company’s website...

July 23, 2014

CAMBRIDGE, England--(BUSINESS WIRE)--Biosceptre, the oncology company developing antibody products that target the nf-P2X7 receptor, announces positive results from its Phase I trial to assess the safety and tolerability of BIL-010t (formerly...

July 22, 2014

MORRISVILLE, N.C.--(BUSINESS WIRE)--Oxygen Biotherapeutics, Inc. (NASDAQ: OXBT) will host a conference call and live audio webcast on Tuesday, July 29, 2014, at 8:30 a.m. ET to report financial results for the 4th quarter and FY 2014.

July 22, 2014

RICHMOND, Va.--(BUSINESS WIRE)--American International Biotechnology, LLC (“AIBioTech”) recently reached a settlement with the U.S. Department of Justice to fully resolve allegations about a contract sales agent’s actions in connection with...

July 22, 2014

LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology announced top-line results from the ExteNET study of its investigational drug neratinib, a Phase III trial in adjuvant breast cancer.

July 22, 2014

LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology announced that its license agreement with Pfizer for the investigational drug neratinib (PB272) has been amended.

July 22, 2014

SAN DIEGO--(BUSINESS WIRE)--La Jolla Pharmaceutical Company Announces Proposed Underwritten Offering of Common Stock

July 22, 2014

COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ: OSIR), announced today that the manuscript from its multi-center (n=20), randomized, controlled clinical trial comparing the safety and effectiveness of Grafix® to control in...

July 22, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Reports Second Quarter 2014 Financial Results

July 22, 2014

PARIS--(BUSINESS WIRE)--EOS imaging reports a 45 percent revenue increase for the first half of 2014.

July 22, 2014

ST. PAUL, Minn.--(BUSINESS WIRE)--3M Introduces the Emphaze AEX Hybrid Purifier

July 22, 2014

SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces that its partner Sage Therapeutics Inc., a biopharmaceutical company developing novel medicines to treat life-threatening, rare central nervous system (CNS)...

July 22, 2014

DIJON, France--(BUSINESS WIRE)--ONCODESIGN, a biotechnology company serving the pharmaceutical industry in the discovery of new therapeutic molecules to fight cancer and other serious illnesses with no known efficient treatment, today announces...

July 22, 2014

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--NeuroPace today announced its partnership with the DARPA RAM teams at UPENN and UCLA to develop new treatments for memory deficits using neurostimulation.

July 22, 2014

SANTA CLARA, Calif.--(BUSINESS WIRE)--XenoPort, Inc. (Nasdaq:XNPT) announced today that it will release its second quarter financial results on August 6, 2014 at approximately 4:30 p.m. Eastern Time. The company will host a conference call at 5:...

July 22, 2014

POMACLE, France--(BUSINESS WIRE)--Regulatory News: Global Bioenergies (Paris:ALGBE) announces today the reception in Pomacle of the fermentation unit and its associated devices. The elements were first assembled at the manufacturer in order to...

July 22, 2014

MIAMI--(BUSINESS WIRE)--OPKO Health Granted Patent from US Patent & Trademark Office for RAYALDEE to treat secondary hyperparathyroidism (SHPT) in patients with stage 3 or 4 CKD and vitamin D insufficiency.

July 22, 2014

GAITHERSBURG, Md. & SEOUL, South Korea--(BUSINESS WIRE)--Seegene Inc. (096530.KQ), a leading developer of multiplex PCR technologies, today announced “MuDT™” technology, the industry’s first real-time PCR technology that will ignite a...

July 22, 2014

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Viamet Pharmaceuticals, Inc. today announced the appointment of Amir Tavakkol, Ph.D., as Chief Development Officer. Dr. Tavakkol brings over 25 years of experience in pharmaceuticals, consumer...

July 22, 2014

DENVER--(BUSINESS WIRE)--Corgenix Medical Corporation will receive a “best abstract” award for its Ebola virus research and present its first-ever oral abstract at the AACC Annual Meeting and Clinical Lab Expo in Chicago.

July 22, 2014

REGENSBURG, Germany--(BUSINESS WIRE)--Results of first-in-human study of Transcatheter Technologies’ TAVI device, TRINITY, are reported in EuroIntervention

July 22, 2014

DEERFIELD, Ill.--(BUSINESS WIRE)--The Board of Directors of Baxter International Inc. (NYSE:BAX) today declared a quarterly dividend of $0.52 per Baxter common share. The dividend is payable on October 1, 2014 to shareholders of record as of...

July 22, 2014

BOSTON--(BUSINESS WIRE)--HighRes Biosolutions was selected by the Scottish Universities Life Sciences Alliance (SULSA) to provide multiple automated robotic platforms to support the UK National Phenotypic Screening Centre.

July 22, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be participating in the BMO Capital Markets 3rd Annual Biotech Corporate Access Day on July 29, 2014. There will be no formal presentations or webcasting at...

July 22, 2014

PITTSBURGH--(BUSINESS WIRE)--Precision Therapeutics announced today that findings from a clinical study supporting performance of the ChemoFx® drug response marker as a predictive marker have been released by British Journal of Cancer, an elite...

July 22, 2014

SAN DIEGO--(BUSINESS WIRE)--The NHLBI, a division of the NIH, has selected Cytori technology for a clinical trial aimed at further improving outcomes in patients receiving LVAD procedures.

July 22, 2014

LITTLE ROCK, Ark.--(BUSINESS WIRE)--Vivione Biosciences is proud to announce that it has received an Association of Analytical Communities certification for its E. coli O157 and Non O157 STEC diagnostic tests for the RAPID-B platform.

July 22, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for claims in the...

July 22, 2014

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--SurModics announced today that it will host a live webcast of its third quarter 2014 conference call on July 31 at 5 p.m. ET and will issue an earnings news release after market closes that afternoon.

July 22, 2014

NASHUA, N.H.--(BUSINESS WIRE)--iCAD, Inc. (Nasdaq:ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced that the Company will...

July 22, 2014

ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical announced CE Mark approval and first use of the FlexAbility™ Ablation Catheter, a novel ablation technology used by electrophysiologists for the treatment of cardiac arrhythmias.

July 22, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea presented data from the Phase 1/2a study of GEN-003 against HSV-2 demonstrating significant, durable T cell responses in vaccinated subjects.

July 22, 2014

DOHA, Qatar & SAN DIEGO--(BUSINESS WIRE)--Sidra Medical and Research Center will house a first-of-its-kind facility, the High-Throughput Genomics Center, to undertake population studies and genetic sequencing for the MENA region. The facility...

July 22, 2014

MEMPHIS, Tenn.--(BUSINESS WIRE)--GTx, Inc. (NASDAQ: GTXI) today announced that the date for its second quarter 2014 financial results press release will be Tuesday, August 5, 2014, prior to the opening of the U.S. stock markets. Similar to the...

July 22, 2014

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences today announced its second-quarter 2014 financial results.